227 related articles for article (PubMed ID: 19931173)
41. [Molecular genetic diagnostics of the cause of ventricular arrhythmias in children].
Brøndberg AK; Bjerre JV; Nielsen JC; Jensen HK
Ugeskr Laeger; 2015 Sep; 177(38):V04150366. PubMed ID: 26376421
[TBL] [Abstract][Full Text] [Related]
42. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
[TBL] [Abstract][Full Text] [Related]
43. Identification of the KCNJ2 Mutation in a Korean Family with Andersen-Tawil Syndrome and Developmental Delay.
Kim NR; Jang JH; Jeon GW; Cho EH; Sin JB
Ann Clin Lab Sci; 2016; 46(1):110-3. PubMed ID: 26927354
[TBL] [Abstract][Full Text] [Related]
44. In vivo and in vitro functional characterization of Andersen's syndrome mutations.
Bendahhou S; Fournier E; Sternberg D; Bassez G; Furby A; Sereni C; Donaldson MR; Larroque MM; Fontaine B; Barhanin J
J Physiol; 2005 Jun; 565(Pt 3):731-41. PubMed ID: 15831539
[TBL] [Abstract][Full Text] [Related]
45. Management and treatment of Andersen-Tawil syndrome (ATS).
Sansone V; Tawil R
Neurotherapeutics; 2007 Apr; 4(2):233-7. PubMed ID: 17395133
[TBL] [Abstract][Full Text] [Related]
46. Andersen-Tawil syndrome: prospective cohort analysis and expansion of the phenotype.
Yoon G; Oberoi S; Tristani-Firouzi M; Etheridge SP; Quitania L; Kramer JH; Miller BL; Fu YH; Ptácek LJ
Am J Med Genet A; 2006 Feb; 140(4):312-21. PubMed ID: 16419128
[TBL] [Abstract][Full Text] [Related]
47. [Andersen-Tawil syndrome: a review of its clinical and genetic diagnosis with emphasis on cardiac manifestations].
Márquez MF; Totomoch-Serra A; Vargas-Alarcón G; Cruz-Robles D; Pellizzon OA; Cárdenas M
Arch Cardiol Mex; 2014; 84(4):278-85. PubMed ID: 25270337
[TBL] [Abstract][Full Text] [Related]
48. Compound heterozygous mutations in
Polyak ME; Shestak A; Podolyak D; Zaklyazminskaya E
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843460
[TBL] [Abstract][Full Text] [Related]
49. [Analysis of clinical phenotypes and KCNJ2 gene mutations in a Chinese pedigree affected with Andersen-Tawil syndrome].
Sun H; Wan N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Oct; 35(5):675-678. PubMed ID: 30298493
[TBL] [Abstract][Full Text] [Related]
50. Impaired cytoplasmic domain interactions cause co-assembly defect and loss of function in the p.Glu293Lys KNCJ2 variant isolated from an Andersen-Tawil syndrome patient.
Déri S; Borbás J; Hartai T; Hategan L; Csányi B; Visnyovszki Á; Madácsy T; Maléth J; Hegedűs Z; Nagy I; Arora R; Labro AJ; Környei L; Varró A; Sepp R; Ördög B
Cardiovasc Res; 2021 Jul; 117(8):1923-1934. PubMed ID: 32810216
[TBL] [Abstract][Full Text] [Related]
51. Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome.
Kukla P; Biernacka EK; Baranchuk A; Jastrzebski M; Jagodzinska M
Curr Cardiol Rev; 2014 Aug; 10(3):222-8. PubMed ID: 24827800
[TBL] [Abstract][Full Text] [Related]
52. Electrophysiologic characteristics of an Andersen syndrome patient with KCNJ2 mutation.
Nagase S; Kusano KF; Yoshida M; Ohe T
Heart Rhythm; 2007 Apr; 4(4):512-5. PubMed ID: 17399643
[TBL] [Abstract][Full Text] [Related]
53. Andersen-Tawil syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity.
Vivekanandam V; Männikkö R; Skorupinska I; Germain L; Gray B; Wedderburn S; Kozyra D; Sud R; James N; Holmes S; Savvatis K; Fialho D; Merve A; Pattni J; Farrugia M; Behr ER; Marini-Bettolo C; Hanna MG; Matthews E
Brain; 2022 Jun; 145(6):2108-2120. PubMed ID: 34919635
[TBL] [Abstract][Full Text] [Related]
54. An andersen-Tawil syndrome mutation in Kir2.1 (V302M) alters the G-loop cytoplasmic K+ conduction pathway.
Ma D; Tang XD; Rogers TB; Welling PA
J Biol Chem; 2007 Feb; 282(8):5781-9. PubMed ID: 17166852
[TBL] [Abstract][Full Text] [Related]
55. Exaggerated Mg2+ inhibition of Kir2.1 as a consequence of reduced PIP2 sensitivity in Andersen syndrome.
Ballester LY; Vanoye CG; George AL
Channels (Austin); 2007; 1(3):209-17. PubMed ID: 18690034
[TBL] [Abstract][Full Text] [Related]
56. Unique post-exercise electrophysiological test results in a new Andersen-Tawil syndrome mutation.
Díaz-Manera J; Querol L; Clarimón J; Yagüe S; Illa I
Clin Neurophysiol; 2011 Dec; 122(12):2537-9. PubMed ID: 21640645
[No Abstract] [Full Text] [Related]
57. Bioinformatics characterisation of the (mutated) proteins related to Andersen-Tawil syndrome.
Polanco C; Uversky VN; Márquez MF; Buhse T; Estrada MA; Huberman A
Math Biosci Eng; 2019 Mar; 16(4):2532-2548. PubMed ID: 31137226
[TBL] [Abstract][Full Text] [Related]
58. Phenotypic Variability of Andersen-Tawil Syndrome Due to Allelic Mutation c.652C>T in the
Onore ME; Picillo E; D'Ambrosio P; Morra S; Nigro V; Politano L
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672523
[TBL] [Abstract][Full Text] [Related]
59. Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7).
Tsuboi M; Antzelevitch C
Heart Rhythm; 2006 Mar; 3(3):328-35. PubMed ID: 16500306
[TBL] [Abstract][Full Text] [Related]
60. Andersen-Tawil syndrome: management challenges during pregnancy, labor, and delivery.
Subbiah RN; Gula LJ; Skanes AC; Krahn AD
J Cardiovasc Electrophysiol; 2008 Sep; 19(9):987-9. PubMed ID: 18554214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
